Ipilimumab - PowerPoint Presentations and PDF Documents

Nivolumab + Ipilimumab

by willow

vs . Platinum-Doublet Chemotherapy . as First-line...

pain in muscles bones and jointslow thyroid hormone levels hypothyr

by susan2

This Medication Guide has been approved by the U.S...

Please refer to CCMB Formulary for Crit

by patricia

ADULT Updated: October 2 8 , 20 20 eria for Use Pa...

Please note, these are the actual video-recorded

by min-jolicoeur

proceedings from the live CME event and may inclu...

Metastatic Renal Cell Carcinoma

by myesha-ticknor

Program Goals. Incidence of RCC in the United Sta...

New Targets and New Treatments in Melanoma

by min-jolicoeur

Brendan D. Curti, MD. Director, Melanoma Program....

YERVOY* (ipilimumab) Product Monograph Page 1of 49

by marina-yarberry

ipilimumab Intravenous Infusion, 5 mg ipilimumab /...

Checkpoint inhibitors for

by paisley

NSCLC. An update. Solange Peters, MD-PhD. Oncology...

Immuno-Oncology Applications

by joy

Lee S. Schwartzberg,. MD, FACP. West Clinic, P.C....

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

by singh

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

by thousandnike

actual. . video-recorded proceedings from the . l...

Nouveautés dans le CBNPC métastatique

by vizettan

Celine Mascaux, MD, . PhD. Multidisciplinary . Onc...

Michael A. Postow, MD

by kittie-lecroy

Michael A. Postow, MD Assistant Attending Physici...

Discussion Outline Cells of the Immune System

by lois-ondreau

Innate Immunity. Receptors on T and B Cells Are S...

Myeloid Updates From the Summer Congresses

by aaron

Program Overview. This program will include a dis...

James L. Gulley M.D. , Ph.D.,

by tatyana-admore

F.A.C.P. .. Head, Immunotherapy Section. Chief, G...

Compendium of ‘Ipilimumab data’

by jane-oiler

Cell Autonomous functions. for CTLA-4. 2. Blocki...

Advances in the Immunotherapy of Solid Tumors

by myesha-ticknor

Malignant Melanoma. (8 minutes). Antoni Ribas, M....

Search Results for 'Ipilimumab'